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Abstract
Oro-facial pain following injury and infection is frequently observed in dental clinics. While neuropathic pain
evoked by injury associated with nerve lesion has an involvement of glia/immune cells, inflammatory hyperalgesia
has an exaggerated sensitization mediated by local and circulating immune mediators. To better understand the
contribution of central nervous system (CNS) glial cells in these different pathological conditions, in this study we
sought to characterize functional phenotypes of glial cells in response to trigeminal nerve injury (loose ligation of
the mental branch), infection (subcutaneous injection of lipopolysaccharide-LPS) and to sterile inflammation (sub-
cutaneous injection of complete Freund’s adjuvant-CFA) on the lower lip. Each of the three insults triggered a spe-
cific pattern of mechanical allodynia. In parallel with changes in sensory response, CNS glial cells reacted
distinctively to the challenges. Following ligation of the mental nerve, both microglia and astrocytes in the trigem-
inal nuclear complex were highly activated, more prominent in the principal sensory nucleus (Pr5) and subnucleus
caudalis (Sp5C) area. Microglial response was initiated early (days 3-14), followed by delayed astrocytes activation
(days 7-28). Although the temporal profile of microglial and astrocyte reaction corresponded respectively to the
initiation and chronic stage of neuropathic pain, these activated glial cells exhibited a low profile of cytokine
expression. Local injection of LPS in the lower lip skin also triggered a microglial reaction in the brain, which
started in the circumventricular organs (CVOs) at 5 hours post-injection and diffused progressively into the brain
parenchyma at 48 hours. This LPS-induced microglial reaction was accompanied by a robust induction of IB-a
mRNA and pro-inflammatory cytokines within the CVOs. However, LPS induced microglial activation did not specifi-
cally occur along the pain signaling pathway. In contrast, CFA injection led to minor microglial morphological
changes and an induction of IB-a mRNA in the CVO regions; a significant increase in IL-1b and IL-6 mRNA started
only at 48 hours post-injection, when the induced pain-related behavior started to resolve. Our detailed analysis of
CNS glial response clearly revealed that both nerve injury and oro-facial infection/inflammation induced CNS glial
activation, but in a completely different pattern, which suggests a remarkable plasticity of glial cells in response to
dynamic changes in their microenvironment and different potential involvement of this non-neuronal cell popula-
tion in pathological pain development.
Introduction
Oro-facial pain is frequently observed in dental clinics.
One of the most common causes of neurogenic oro-
facial pain is traumatic lesion of the trigeminal nerve
[1]. Certain dental treatments, such as extraction of
impacted third molars or extraction of endodontic mate-
rial into the mandibular canal, are frequently implicated.
Orthognathic surgery and surgery to the middle third of
the face have also been implicated. Other events, such
as stretching of the nerve, trapping of the nerve in scar
tissue, or compression by inflammatory reactions, are
also likely to be the causes. This type of hypersensitivity
is severely debilitating, becomes chronic, can last for
several months or years, even after the healing of the
original trauma. Another oro-facial pain that has a well-
understood etiology is that associated with infection.
Infection or inflammation in teeth and periodontal tis-
sues or in mucogingival tissues lead to inflammatory
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infection declines in a predictable fashion as the infec-
tion recedes and there is tissue repair [2].
The sensory innervation of the oro-facial area is pro-
vided by branches of the trigeminal nerve. The great
majority of trigeminal sensory neurons have their cell
bodies clustered in the trigeminal ganglion [3]. Their
central branches enter the brainstem at the level of the
pons and end mostly in the principal sensory and spinal
trigeminal nuclei [4]. Sensory information, including
nociceptive information is conveyed via second-order
neurons to higher centers [4]. It has been established for
a long time that neurons are responsible not only for
the transmission but also for the modulation of sensory
information, including pain-related information. How-
ever, considerable data is emerging indicating that a
variety of non-neuronal cells along the neuronal pain
signaling pathways play an important modulatory role,
both in the CNS and in the periphery [5]. Along these
lines, cells of the immune system are recruited to the
sites of peripheral injury and inflammation. Through a
coordinated release of multiple classes of inflammatory
mediators, these immune cells contribute to the activa-
tion and sensitization of the nociceptors in the primary
afferents [6]. In the CNS, although they act as bystan-
ders in nociceptive processes under normal conditions,
both microglia and astrocytes become activated follow-
ing damage to the peripheral or central nervous systems,
release mediators to induce or/and maintain hyperexcit-
ability in pain signaling and thereby contribute to
abnormal nociception [7]. Despite that infection or
inflammation can also stimulate the glia, the involve-
ment of CNS glia in the modulation of inflammatory
pain was not clearly identified.
Tissue macrophages are innate immune cells with
well-established roles in the primary response to patho-
gens, and also in tissue homeostasis. Macrophage activa-
tion has a large spectrum of profiles, ranging from
classically activated M1 macrophages, which have the
capability to produce cytokines that enhance the
immune response, to alternatively activated M2 macro-
phages, which possess important immuno-modulatory,
tissue repair and remodeling properties [8]. Inflamma-
tory pathogens favor macrophage differentiation toward
an M1 profile, while tissue debris leads macrophage into
regulatory and wound-healing M2 macrophages [9]. As
resident macrophages in the CNS, microglia also have
remarkable plasticity that allows them to efficiently
respond to environmental signals and lead to distinct
signaling cascade within the cells and different morphol-
ogy changes or secretory activities [10]. There is no clas-
sification of activated microglia similar to that developed
for activated macrophages. However, it is predictable
that the response of microglia to infection, to remote
damage on the peripheral tissue or nerve, and to direct
lesion on the brain or spinal cord could be different,
which would lead to different functional consequences.
To better understand the multi-dimensional profiles of
glial activation in response to different insults and to
clarify the potential contribution of glial cells in different
types of pathological pain, in this study we compared
the activation of microglia and astrocytes following
nerve injury, infection and inflammation in the oro-
facial region. Three animal models of pathological pain
were used, including 1) neuropathic pain model follow-
ing trigeminal nerve injury, 2) local infection-like
pathology following subcutaneous injection of a bacterial
toxin, lipopolysaccharide (LPS) and 3) local sterile
inflammation following subcutaneous injection of com-
plete Freund’s adjuvant (CFA). Subsequently, we ana-
lyzed the phenotype and functional characteristics of
glial cells in response to the above insults and correlated
the observed changes with pain-related behavior.
Materials and methods
Animals
Adult male Sprague-Dawley rats (Charles River, Que-
bec, Canada) were used and weighed 250-275 g at time
of surgery. Before surgery, they were acclimatized to
standard laboratory conditions (14-h light, 10-h dark
cycle) and given free access to rat chow and water. All
protocols were performed in accordance with guide-
lines from the Canadian Council on Animal Care and
the International Association for the Study of Pain,
and were approved by the McGill University Animal
Care Committee.
Animal models
Mental nerve ligation
Rats were deeply anesthetized with isoflurane. As
described previously [11], under standard surgical asep-
tic conditions, the mental nerve was exposed bilaterally
starting at its exit point from the mental foramen.
Approximately 6 mm of nerve was freed of adhering tis-
sue and two silk ligatures (8.0) were tied loosely around
it, as close as possible to the exit of the nerve from the
bone, but with approximately 2 mm between ligatures.
The tightness of the ligature was verified as the knots
were just barely movable around the mental nerve.
Sham-operated animals underwent the exact same surgi-
cal procedure with the exception of the nerve ligation.
Lesions were performed bilaterally. Also, it has been
reported that direct grooming behavior, indicative of
pain, were more consistently observed following bilater-
ally lesion [12].
Subcutaneous injection of LPS
Under brief anesthesia with isoflurane, Lipopolysacchar-
ide (LPS), from Escherichia coli strain 055:B5 (Sigma,
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weight, dissolved in 50 μl saline) close to the midline of
the lower lip. Dose was selected according to literature
where systemic or local LPS induced a significant
inflammatory reaction and adjusted in our pilot study
for pain response.
Subcutaneous injection of CFA
t h eC o m p l e t eF r e u n d ’sA d j u v a n t( C F A )s o l u t i o nw a s
prepared by thorough mixing 10 ml of Incomplete
Freund’s Adjuvant (IFA) (Difco laboratories) with
100 mg desiccated mycobacterium tuberculosis, strain
H37Ra (Difco laboratories). Once prepared, it was kept
at 4°C until use. Under brief anesthesia with isoflurane,
av o l u m eo f7 0μl of CFA was injected subcutaneously
in the middle part of the lower lip. Dose was established
according to previous study in inducing inflammatory
pain in paw and adjusted to the injection site (lower lip).
Behavioral testing
Animals were habituated to the testing environment
daily for at least two days before baseline testing. All
animals were assessed for mechanical allodynia before
surgery or injection and at specified time points after
nerve injury, local LPS and CFA injection, respectively,
until they were sacrificed for histological studies.
Mechanical sensitivity was assessed using calibrated von
Frey Hairs as described [13]. Animals were placed in
boxes on an elevated metal mesh floor and allowed
40 to 60 min for habituation before testing. A series of
von Frey filaments with logarithmically incrementing
stiffness (Stoelting) was applied perpendicular to the
mid-area of the lower lip. The 50% head escape thresh-
old was determined using Dixon’s up-down method as
previously described [14].
Tissue preparation
For histological studies
Rats were deeply anaesthetized with ketamine/xylazine
and then perfused transcardially with 0.9% saline fol-
lowed by 4% paraformaldehyde (PFA) in 0.1 M sodium
phosphate buffer (pH 7.4). Brains were removed and
placed in the same fixative overnight at 4°C then trans-
ferred to 30% sucrose in phosphate buffer at 4°C for
cryoprotection for at least 18 hours. Brains were cut
transversely into 30-μm-thick sections on a sliding freez-
ing microtome, collected in an anti-freeze solution
[0.05M sodium phosphate buffer (pH 7.3) containing
30% ethylene glycol and 20% glycerol] and stored at
-20°C until use.
For real time PCR experiments
Rats were deeply anaesthetized with isoflurane and
decapitated, then segments of brainstem, including the
Sp5C and AP areas were quickly removed and snap fro-
zen in liquid nitrogen and stored at - 80°C until use.
Immunohistochemistry (IHC)
A standard bright field immunohistochemistry protocol
was applied to characterize the spinal glial cell reaction
to peripheral nerve injury, to LPS and to CFA injection.
Free-floating sections were first extensively washed in
phosphate buffer and then incubated overnight at 4°C
with the following antibodies, diluted in phosphate buf-
fer containing 0.25% triton-X and 0.1% normal goat
serum: rabbit anti-ionized calcium-binding adaptor
molecule 1 (Iba-1) polyclonal antibody (for microglia
and macrophages; 1:1000; Wako Chemicals, Richmond,
VA) and rabbit anti-glial fibrillary acid protein (GFAP)
polyclonal antibody (for astrocytes; 1:1000; DakoCyto-
mation, Carpinteria, CA) and, after washing in phos-
phate buffer then incubated with a biotinylated
secondary antibody (1:1000, Vector Laboratories,
Canada), followed by an avidin-biotin-peroxidase com-
plex (Vectostain ABC Elite Kit, Vector Laboratories).
After several washes in phosphate buffer, tissue sections
were reacted in 0.05% diaminobenzidine and 0.003%
hydrogen peroxide. Sections were then mounted on
Super Frost plus slides, counterstained with thionin to
facilitate the visualization of anatomical boundaries,
dehydrated through graded concentrations of ethanol
and coverslipped with DPX.
To identify the phenotype of IL-1b expressing cells in
LPS-treated rats, immunofluoresecent staining with anti-
bodies against IL-1b (1:500, Santa Cruz) and OX-42
(1:1000, Cedarlane) was performed in brain CVO
regions.
In situ Hybridization (ISH)
Detection of mRNAs encoding IB-a and IL-1b was
performed on brain sections using 35S-labeled ribop-
robes. cDNA fragments containing 1114 bp (Genebank
U36277) and 700 bp (Genebank NM_031512) were used
as probes for IB-a and IL-1b, respectively. Riboprobe
synthesis and hybridization were performed as per a
previously described protocol [15]. Briefly, plasmids
were linearized, sense and anti-sense cRNA probes were
synthesized with appropriate RNA polymerase. Sections
were postfixed in 4% PFA and digested by proteinase K
(10 μg/ml, at 37°C for 20 min). After which brain sec-
tions were rinsed in water and by a solution of 0.1 M
triethanolamine (TEA, pH 8.0), acetylated in 0.25%
acetic anhydride in 0.1 M TEA and then dehydrated.
Hybridization of the sections by riboprobe involved a
10
6 cpm/ml/slide of hybridization mixture and incuba-
tion at 55°C overnight in a slide warmer. Slides were
then rinsed in standard saline citrate buffer (1X SSC:
0.15 M NaCl, 15 mM trisodium citrate buffer, pH 7.0)
a n dd i g e s t e db yR N a s eAa t3 7 ° C( 2 0μg/ml), rinsed
again in descending concentrations of SSC, and dehy-
drated through graded concentrations of ethanol.
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Rochester, NY) for 2-4 days and dipped in NTB2
nuclear emulsion (diluted 1:1 with distilled water,
Kodak). Slides were kept at 4°C for 2-4 weeks safe from
light and developed in D19 developer (Kodak).
RNA extraction and real-time quantitative PCR
Total RNA was extracted from segments of brainstems,
including the Sp5C and AP areas using the Rneasy Lipid
Tissue Mini Kit (QIAGEN). Synthesis of cDNA from
total RNA was performed with the SuperScript VILO
cDNA Synthesis Kit (Invitrogen). Primers were pro-
duced by QIAGEN QuantiTect (IL-1b-QT00181657,
IL6-QT00182896, GAPDH-QT00199633). Fifteen sam-
ples were analysed (Naïve; nerve injured-day 7; local
LPS-injected-5 hours; local CFA- injected-5 hours; local
CFA-48 hours; n = 3/group). Experiments were per-
formed in triplicate using an applied Biosystems
7900HT Fast Real-Time PCR System. Levels of target
mRNAs were normalized to the housekeeping gene
GAPDH. Fold changes versus naïve animals were ana-
lyzed using the comparative Ct (dCT) method [16].
Image analysis and cell counting
Images were captured using Olympus BX51 microscope
(Tokyo, Japan) equipped with a colour digital camera
(Olympus DP71). Cell counting of both Iba-1 and GFAP
positive cells was performed on digitized images.
Defined areas of interest (AOIs) on Sp5C and Pr5 were
selected. Only a well-defined thionine-stained nucleus
associated with a well-circumscribed, immunopositive
cell body was considered as a particular phenotype, e.g.,
Iba-1+ microglia and GFAP+ astrocytes. The cell count-
ing was conducted on 3-4 sections per animal and five
animals in nerve injured group and three animals in
sham-operated group.
Statistical analysis
All data are presented as means ± SEM. Statistic signifi-
cance was determined using: 1) Two way ANOVA ana-
lysis for behavioural data in Figure 1; 2) unpaired t-test
for the difference of cell numbers between injured- and
sham-operated group in Figure 2 and Figure 3; and
unpaired t-test for the difference of cytokine expression
in each challenged group vs. naive in Figure 10. The cri-
terion for statistical significance was p < 0.05.
Results
Nerve injury, infection and inflammation induced
mechanical hypersensitivity
After bilateral mental nerve ligation, rats developed
mechanical allodynia, as tested in the area of the lower lip
close to the midline (Figure 1A). From post-injury day 3
onwards, the head escape threshold elicited by the
calibrated Von Frey hair was significant lower than the
baseline before surgery; between 0.51 ± 0.13 g to 0.78 ±
0.06 g during the first 10 days, and then remained stable
around 1.0 g to the end of testing period (day 27); in con-
trast, the threshold before surgery was 3.84 ± 0.186 g. The
hypersensitivity observed up to 10 days may be in part
caused by the incisions which are very close to the testing
area. In agreement with this, sham-operated animals also
manifested a mechanical hypersensitivity which was signif-
icant at 3 days post-surgery and recovered after 10 days.
Rats receiving subcutaneous injection of LPS in the
lower lip skin developed an acute mechanical allodynia
(Figure 1B) which was significant at 5 hours post-injec-
tion (1.48 ± 0.17 g) and disappeared progressively after-
wards (2.84 ± 0.31 g at 24 hrs and 3.65 ± 0.22 g at 48
hrs); baseline value was 3.79 ± 0.47 g. The head escape
threshold in CFA injected rats started to decrease
5 hours post-injection (0.66 ± 0.18 g), reached its lowest
level at 24 hours (0.4 ± 0.07 g) and started to recover
after 48 hours (Figure 1C).
Peripheral nerve injury triggered glial activation
in the brain
Ligation of mental nerve did trigger a reaction of both
microglia and astrocytes within the trigeminal complex
in the brainstem area. The anatomical distribution (both
spatial and temporal) and morphological changes of
activated microglia and astrocytes were visualized using
Iba-1 and GFAP, respectively, as cellular markers. Iba-1
labeled microglia were distributed almost homogenously
throughout the entire brainstem in sham-operated rats.
In nerve injured animals, Iba-1 staining was significantly
increased in the trigeminal nuclear complex, especially
in the principal sensory nucleus (Pr5) and subnucleus
caudalis (Sp5C) area (Figure 2). Activated microglia in
Pr5 and in Sp5C were characterized by a dramatically
enlarged soma, short/thick and fewer ramifications than
resting microglia (Figure 2A, inserts). A significant glial
cell proliferation was observed 14 days after nerve liga-
tion. The number of Iba-1
+ cells in Pr5 and Sp5C
regions (27.18 ± 1.64, 18.3 ± 1.6 respectively) in nerve
injured rats was 2-3 times higher than (12.23 ± 0.86 in
Pr5 and 9.54 ± 0.57 in Sp5C) in sham-operated rats
(Figure 2B). GFAP stained astrocytes displayed signs of
activation in the trigeminal nuclei (Pr5 and Sp5C)
(Figure 3) having major hypertrophic changes in mor-
phology, with large, thick branches (Figure 3A, inserts)
and a relatively slight increase in cell density (24.22 ±
0.74-injured vs 16.12 ± 1.04-sham in Pr5 and 28.51 ±
0.82-injured vs. 17.74 ± 0.71-sham in Sp5C) (Figure 3B)
The temporal profile of microglial and astrocyte activa-
tion in trigeminal nuclei following mental nerve injury
was similar to what we have previously reported spinal
glial activation following sciatic nerve injury [17].
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Page 4 of 18Figure 1 Trigeminal nerve injury, local infection and inflammation induced mechanical allodynia of the lower lip area. A). In rats having
mental nerve (MN) ligation (n = 5), head escape threshold to von Frey stimulation decreased shortly after the injury (day 3) and remained low
until the end of experiment (day 27). The decrease threshold observed in sham-operated rats (n = 3) shortly post-surgery disappeared
completely after 10 days. B). Subcutaneous injection of LPS induced an acute mechanical hypersensitivity of the lower lip, which was significant
at 5 hours post-injection (n = 5/group). C). CFA injection (n = 3 saline, n = 5 CFA) triggered mechanical allodynia during first three days post-
injection and then progressively disappeared. ** P < 0.01, *** P < 0.001, compared to sham-operated group at their corresponding time point.
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Page 5 of 18Figure 2 Microglial reaction in response to mental nerve ligation at 14 days post-injury. A). Immunostaining for Iba-1 in four trigeminal
subnuclei, including principal sensory nucleus (Pr5), spinal oralis (Sp5O), spinal interpolaris (Sp5I) and spinal caudalis (Sp5C). A significant increase
in Iba-1 immunoreactivity was observed in nerve injured rats, particularly in Pr5 and Sp5C, together with remarkable changes in microglial cell
shape (inserts). Note there are no significant changes of Iba-1 staining and microglial cells shape in medullar CVOs, area postrema (AP).
Diagrams were adapted and modified from [59]. Orange shadowed area indicated where the pictures were taken. Scale bar: 50 μm B). The
density of Iba-1+ cells in Pr5 and Sp5C areas was significant higher in injured group than that of sham-operated. Data are expressed as Mean ±
SEM. ### P < 0.001, compared to sham-operated group.
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Page 6 of 18Figure 3 Astrocyte reaction in response to mental nerve ligation at 14 days post-injury. A). Immunostaining for GFAP in four trigeminal
subnuclei, including the principal sensory nucleus (Pr5), spinal oralis (Sp5O), spinal interpolaris (Sp5I) and spinal caudalis (Sp5C). There was a
significant increase in GFAP immunoreactivity in nerve injured rats, which was more prominent in Pr5 and Sp5C, together with remarkable
changes in astrocyte cell shape (inserts). Note there are no significant changes of GFAP staining in medullar CVOs, area postrema (AP). Diagrams
were adapted and modified from [59]. Orange shadowed area indicated where the pictures were taken. Scale bar: 50 μm. B). The density of
GFAP+ cells in Pr5 and Sp5C areas was significant higher in injured group than that of sham-operated. Data are expressed as Mean ± SEM. ###
P < 0.001, compared to sham-operated group.
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lowed by a delayed astrocyte activation (d7-d28) (Figure
4). No significant changes in microglia or astrocytes were
detected in other brain regions, including those related to
the pain perception and modulation, such as the thalamus
and somatosensory cortex (data not shown).
Oro-facial infection-triggered glial reaction in the brain
To analyze the glial response to local oro-facial infec-
tion/inflammation, in addition to the trigeminal complex
i nt h eb r a i n s t e m ,w eh a v ep a i ds p e c i a la t t e n t i o nt o
regions where the capillaries in these structures are
fenestrated and the blood brain barrier (BBB) is not
complete, including circumventricular organs (CVOs),
ventricles and choroid plexus. Five hours following LPS
injection, at a time where an acute mechanical allodynia
was detected in the lower lip, we found some morpholo-
gical changes of Iba-1
+ microglia in the CVOs, such as
area postrema (AP) where the soma of these Iba-1
+ cells
started to enlarge, and displayed thick and rigid pro-
cesses (Figure 5, mid-column). Some enlarged Iba-1
+
cells also appeared at the edge of the grey matter (Fig-
u r e5 ,m i d - c o l u m n ) ,b u tw ed i dn o to b s e r v ea n ye v i -
dence of microglial activation restricted to the
trigeminal complex. However, 48 hours later, when the
mechanical hypersensitivity in the lower lips was com-
pletely resolved, scattered, enlarged, Iba-1 intensely
labeled microglia were found across the entire parench-
yma (Figure 5, right-column). No significant changes on
GFAP labeled astrocytes were detected at any time, in
any regions of the brain (data not shown).
Oro-facial sterile inflammation-triggered glial reaction
in the brain
Compared with LPS induced CNS glial response, local
CFA injection only triggered a minor morphological
change on Iba-1
+ microglial cells in CVOs (Figure 6).
No significant changes, including intensity of Iba-1
labeling and iba-1 labeled cell shape were detected in
the brain parenchyma (Figure 6). No significant changes
on GFAP labeled astrocytes were detected at any time,
in any regions of the brain (data not shown).
Activation of NF-B and expression of proinflammatory
cytokines following nerve injury, infection and sterile
inflammation in oro-facial area
Secretion of proinflammatory cytokines is one of the key
elements of glial activation. Many in vitro and in vivo
data suggested that proinflammatory cytokines, together
with other inflammatory mediators can directly excite
neurons and act as signaling molecules between acti-
vated glial cells and neurons. To further understand the
functional aspects of glial activation in response to dif-
ferent pain-related insults, in addition to anatomical dis-
tribution and morphological changes, we also examined
t h ea c t i v i t yo fN F - B (a transcription factor responsible
for the activation of many inflammation related genes)
and the capability of activated glial cells to produce
proinflammatory cytokines.
For this, we used initially in situ hybridization
approaches to investigate mRNA expression of inhibitor
of NF-B( I B-a), an index for NF-B activity, and
cytokine IL-1b expression in the brains of three different
models. Surprisingly, although both microglia and astro-
cytes were highly activated in the Sp5C area, we were
not able to detect the mRNA expression for IB-a and
IL-1b in the corresponding regions from day 3 to day
14 post-injury. Figure 7 illustrates the microglial and
astrocyte activation evidenced by Iba-1 and GFAP stain-
ing (arrows) in Sp5C regions and lack of IB-a and IL-
1b mRNA positive signals with ISH detection at 14 days
following mental nerve ligation. However, in local
Figure 4 Temporal profile of microglial and astrocyte activation following ligation of the mental nerve. Microglia and astrocytes were
immunolabeled with Iba-1 and GFAP, respectively. The intensity of Iba-1 immunoreactivity (ir) in Sp5C area was increased between days 3-days
14 and sharply diminished after days 28 post-injury whereas GFAP immunoreactivity increased significantly after days 14 and remained elevated
at least until days 28. Scale bar: 50 μm.
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a (Figure 8A) and IL-1b (Figure 8B) mRNAs were
highly expressed and restricted to the CVOs, ventricles
and choroid plexus; some of these IL-1b expressing cells
in CVOs were OX-42 positive microglia (Figure 8C).
The positive hybridization signals were significantly
reduced at 48 hours. Either at 5 hours, when animals
showed an acute painful response or at 48 hours, when
Iba-1 labeled enlarged microglia were found in the brain
parenchyma, none of IB-a and IL-1b expression was
detected with in situ hybridization in the pain transmis-
sion-related structures, such as the trigeminal nuclei
(Figure 8). In CFA treated rats, only IB-a mRNA was
detected in the CVOs (Figure 9).
Having concerns on the sensitivity of the in situ hybri-
dization approach, we decided to examine the expres-
sion of these inflammatory molecules (IL-1b and IL-6)
with real-time PCR. Segments of brainstem, including
the Sp5C and AP areas, were collected from rats having
nerve injury (7 days), LPS injection (5 hours), and CFA
injection (5 and 48 hours). Results yielded from PCR
amplification demonstrated that basal expression of IL-
1b (6.7 ± 0.05 × 10
-5 fold changes vs. GAPDH) and IL-6
(9.92 ± 0.15 × 10
-4 fold changes vs. GAPDH) in naïve
brain was extremely low (Figure 10A, C). Compared
with naïve animals, mental nerve ligation did increase
the expression of both IL-1b and IL-6 mRNAs in the
brainstem, but only very slightly, as we detected a
1.23 ± 0.09 fold increases for IL-1b and a 1.21 ± 0.25
fold increases for IL-6 (Figure 10B, D), values which
explain why we were not able to detect the signals with
in situ hybridization. In contrast, subcutaneous injection
of LPS in the lower lip induced a dramatic increase of
both IL-1b (17.26 ± 1.74 fold increases vs. naive) and
IL-6 (7.81 ± 1.39 fold increases vs. naive) in the brain
(Figure 10B, D). CFA injection-stimulated cytokine
expression in the brain significantly increased only after
48 hours, with a 2.92 ± 0.21 fold increases for IL-1b and
1.40 ± 0.08 fold increases for IL-6 (Figure 10B, D).
Discussion
In this study, we characterized the morphological and
functional profile of CNS glial cells in response to per-
ipheral nerve injury, to local oro-facial infection and to
inflammation. All these three insults triggered a specific
pattern of mechanical allodynia on the lower lip. Our
Figure 5 Subcutaneous injection of LPS in the lower lip induced microglial activation in the brain. In response to local LPS
administration, microglial activation was first observed in the CVOs, such as the area postrema (AP) and at the edge of the grey matter at 5
hours post-injection. At 48 hours, activated microglia were dispersed throughout the parenchyma. Activated microglia exhibited remarkable
changes in microglial morphology (inserts). Diagrams were adapted and modified from [59]. Orange shadowed area indicated where the
pictures were taken. Scale bar: 50 μm.
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gered both microglia and astrocyte activation in the
region of the central terminals of the damaged nerve
fibres. However these activated glial cells exhibited low
capacity to produce proinflammatory cytokines. The
spatial and temporal profile of this glial activation was
closely correlated with the development of mechanical
allodynia following nerve ligation. 2) LPS injection, a
model of oro-facial infection, triggered an acute micro-
glial reaction, starting from the CVOs, which diffused
progressively into the CNS parenchyma; and was char-
acterized by a robust induction of IB-a and IL-1b, IL-6
mRNAs in the CVOs. Most likely this is an acute CNS
inflammatory response, not directly relevant to the local
mechanical hypersensitivity following LPS injection. No
significant astrocyte activation was observed. 3) CFA
injection, a model of oro-facial sterile inflammation,
only triggered minor changes on microglial morphology
and a transient induction of IB-a mRNA, restricted in
the CVOs, and a slight increase of IL-1b and IL-6
mRNAs at late time point, which is not likely correlated
to the pain development. Therefore we conclude that
nerve injury-induced microglial activation is character-
ized by morphological changes with a low profile of
cytokine expression, whereas infection-induced micro-
glial activation is accompanied by high levels of cytokine
production. Astrocyte response was significant only fol-
lowing nerve injury.
Three animal models used in this study provided
diversified stimuli to examine the plasticity of CNS glial
cells and their potential contribution in the development
of pain
Lesion on the peripheral nerve is a major cause for neu-
ropathic pain. Many functional and phenotypic changes
occur along pain conducting pathways, from peripheral
terminals to higher centers in the brain. In addition, as
most animal models of neuropathic pain entail lesions
o fm i x e dn e r v e ss u c ha st h es c i a t i cn e r v e ,w h i c hp o s -
sesses sensory, motor and sympathetic fibers, the model
that we used in this study, loose ligation on the mental
nerve offered a unique opportunity to study the effects
of lesion on sensory fibers, since in rats the mental
nerve is almost exclusively sensory in origin [18,19]. As
a component of the cell wall of Gram-negative bacteria,
lipopolysaccharide endotoxin (LPS) is a well established
agent to mimic the endogenous effect during infection
and sepsis. Systemic injection of LPS induces fever and
Figure 6 Subcutaneous injection of CFA in the lower lip induced microglial activation in the brain. In response to local CFA, microglial
activation was only observed in the CVOs, such as the area postrema (AP) (upper row), with minor changes in microglial morphology at 5 and
48 hours post-injection (middle row). No activated microglia were found at the edge of the grey matter. Diagrams were adapted and modified
from [59]. Scale bar: 50 μm.
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Page 10 of 18Figure 7 Detection of IB-a and IL-1b mRNAs on activated glial cells in Sp5C with in situ hybridization. Although increases in Iba-1 and
GFAP immunoreactivities were found in Sp5C areas 14 days after the ligation on the mental nerve (arrows), no positive hybridization signals for
IB-a or IL-1b mRNAs were detected in these regions (lower panels). Scale bar: 500 μm.
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Page 11 of 18Figure 8 In situ hybridization detected robust expression of IB-a and IL-1b mRNAs in the brain following local LPS injection. A).I B-a
mRNA was dramatically increased in the CVOs, such as SFO, meninges and ventricle related structures at 5 hours post LPS injection, and this
increase was significantly reduced at 48 hours. No positive signals were detected within the parenchyma, including Sp5C. B). IL-1b mRNA was
also induced in the CVOs, such as SFO, AP and choroid plexus at 5 hours post LPS injection, it was almost completely disappeared at 48 hours.
No positive signals were detected within the parenchyma, including Sp5C. C). Double immunofluorescent labelling demonstrated that some of
IL-1b
+ cells are OX-42
+ microglia. Scale bar: 500 μm in A and B; 50 μmi nC .
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Page 12 of 18Figure 9 In situ hybridization detected robust expression of IB-a mRNA in the brain following local CFA injection. A).I B-a mRNA was
dramatically increased in the CVOs, such as SFO and AP at 5 hours post CFA injection, and this increase was reduced at 48 hours. No positive
signals were detected within the parenchyma, including the Sp5C. B). No positive in situ hybridization signals for IL-1b mRNA were detected at
any examined time points (5 and 48 hours) after CFA injection, in any region of the brain. Scale bar: 500 μm.
Lee et al. Molecular Pain 2010, 6:79
http://www.molecularpain.com/content/6/1/79
Page 13 of 18septic shock and is associated with an increase of differ-
ent cytokines, including TNF-a,I L - 1 b and IL-6, in the
blood circulation [20,21] and in the brain [22,23] in a
pattern similar to that seen in natural infection. How-
ever, the impact of a local, peripheral injection of LPS
on the CNS and relationship with local LPS induced
pain behavior were not yet clarified. CFA is an immune
response enhancer, effective in stimulating cell-mediated
immunity and may lead to increase of the production of
certain immunoglobulin in the absence of an infection.
Due to its painful reaction and its immunopotentiator
properties, CFA is frequently used to study sterile
inflammatory reaction-associated pain, including arthri-
tis [24,25]. In this study, we used CFA as a model of a
sterile inflammatory condition.
Nerve injury and infection/inflammation signal the CNS
glial cells through different pathways
Within the central nervous system, microglia and astro-
cytes represent two highly reactive intra-parenchymal
cell populations. Microglia, which originate from the
bone marrow, provide immune surveillance of any
exogenous or endogenous perturbation [26]. Activated
microglia are characterized by a specific morphology,
proliferation, increased expression of cell surface mar-
kers or receptors, and changes in functional activities
such as migration to areas of damage, phagocytosis, and
production/release of proinflammatory substances [27].
Developmentally different from microglia, astrocytes,
normally support neurons by maintaining metabolic
homeostasis, and also respond to different insults. The
prominent morphological feature of astrocyte activation
is hypertrophy. Functionally, this activation is mani-
fested by increased production of a variety of trophic
factors and by an alternation of astrocyte function in the
maintenance of homeostasis. The fact that peripheral
n e r v ei n j u r yc a ni n d u c em i c r o g lial/astrocyte activation
has been demonstrated in several chronic neuropathic
pain models [28-30]. Our detailed systematic analysis of
mental nerve injury induced microglia and astrocyte
activation in the subnucleus of trigeminal complex
revealed a similar pattern of glial activation to that pre-
viously described in the spinal cord following sciatic
nerve injury [17]. CNS glial response following
Figure 10 Expression of proinflammatory cytokines IL-1b and IL-6 in the brainstem measured by quantitative real time PCR. A). IL-1b/
GAPDH mRNA expression in each group. B). Fold changes in IL-1b expression (challenged rats vs. naïve rats). C). IL-6/GAPDH mRNA expression
in each group. D). Fold changes in IL-6 expression (challenged rats vs. naïve rats). Data are expressed as Mean ± SEM. * P < 0.05, ** P < 0.01
compared to naïve rats. N = 3/group.
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Page 14 of 18peripheral nerve damage occurs through a neural path-
way, at the region where the central terminals of the
damaged nerve fibers end. In the current study, we
observed that mental nerve ligation evoked microglia
and astrocytes activation predominated at Sp5C where
nociceptive primary afferents terminate, and at Pr5 area
where larger A-beta afferent fibers synapse. Microglial
response preceded that of astrocytes and astrocyte acti-
vation outlasted transient microglial activation. While
dramatic morphological changes were observed in both
microglial and astrocyte responses, cell proliferation
also occurred, but the increase in cell numbers was
higher for the microglial cell population. We did not
find evidence of any significant changes in other pain
related regions, either through direct projection from
the trigeminal brain stem complex, or through multisy-
naptic pathways using relays in the reticular formation
and adjacent brainstem areas, including thalamus,
superior colliculus, periaqueductal gray and others
(data not shown), although some previous studies
observed glial activation in pain modulatory circuitry,
such as rostral ventromedial medullar in a similar
nerve injury model [31]. In contrast, inflammatory sig-
nals triggered in the periphery following either LPS or
CFA injection likely reach the CNS via an endocrine-
like mechanism. Indeed, in our study, the subcuta-
neous injection of LPS triggered an acute brain micro-
glial response, including both morphological changes
and a robust induction of cytokine expression, which
was initiated from the CVOs, membrane lining on the
ventricles and choroid plexus. What is common to
these regions is that they are devoid of blood-brain
barrier, therefore blood borne molecules have easier
access to the CNS than in other regions. This is in
agreement with previous observations that the direct
action of LPS on cells bearing LPS receptor-CD14
within these organs initiates a rapid activation of mye-
loid derived cells, including microglia and perivascular
macrophages [32,33]. Cytokines and other inflamma-
tory molecules released by these activated microglia/
macrophages spread the signals into the adjacent par-
enchyma in a migratory-like pattern [22]. We show
that CFA seems capable of stimulating the glial reac-
tion in the brain, but the pattern was similar to that
following LPS.
Characteristics of nerve injury and infection/
inflammation-induced microglial activation
Microglia share the same origin with circulating mono-
cytes and peripheral tissue macrophages and indeed
represent CNS tissue specific macrophages. Therefore, it
is not surprising that ther ec o u l db eaw i d er a n g eo f
phenotypic and functional similarities between microglia
cells and peripheral macrophages. Mainly based on in
vitro observations, macrophage activation has been
described as belonging to two main types, classically
activated (or inflammatory) M1 and alternatively acti-
vated M2 macrophages. Each subpopulation is charac-
terized by a distinct profile of gene expression and,
accordingly, each has different functions [9,34]. M1
macrophages produce high levels of proinflammatory
cytokines and mediators which are vital components of
host defence [35]. M2 macrophages have rather an anti-
inflammatory profile and are involved in tissue remodel-
ling [36]. A recent in vivo study demonstrated that, in
injured spinal cords, macrophages/microglia cells exhibit
two phenotypes, while the M1 is neurotoxic, M2 pro-
motes a regenerative growth response [37]. In the cur-
rent in vivo s t u d y ,w ep r o v i d ee v i d e n c et h a tt h e r ei sa
distinctive phenotype of microglial activation in
response to nerve lesion, inflammation and infection.
Microglial activation following nerve lesion was charac-
terized by morphologic changes and cell proliferation,
but low levels of proinflammatory cytokine expression.
In this, it resembles the M2 macrophage activation in
peripheral tissue. In contrast, LPS-induced microglial
activation possessed a typical inflammatory phenotype,
compared to the one of peripheral M1 macrophages.
Thus, the morphological and functional changes in
microglia reflect altered activation states induced by dif-
ferent signals that arise from injured neurons or from
circulating immune mediators. In addition to distinct
phenotype of macrophage/microglia activation, our
results also suggested that, indeed, the microglial cells
may be a heterogeneous population, since monocytes in
the blood have been characterized as inflammatory
(CCR2
high,C X 3 C R 1
low and GR1
+)a n dr e s i d e n t
(CCR2
low CX3CR1
high GR1
-) subpopulations [38]. Spe-
cific monocyte populations might give rise to specific
tissue macrophages [39], including microglia.
Potential contribution of CNS glial cells to pain in the
different experimental conditions
In the last decades, considerable evidence was obtained
supporting the concept that activated glial cells can con-
tribute, in one way or another, to experimental pain
states. More convincing data were accumulated in mod-
els of neuropathic pain following nerve lesions. The
concept of glial involvement in pain modulation was
initially developed following studies in which there was
spinal glial activation [40], and was further supported by
evidence of trigeminal glial activation in oro-facial pain
conditions. Intracisternal administration of inhibitors for
p38 or ERK1/2, MAPKs phosphorylated on activated
glial cells, produced an anti-allodynic effect following
infraorbital nerve injury [41]. Microglia inhibitor, mino-
cycline, reduced the tactile hypersensitivity following
transection of inferior alveolar nerve and mental nerve
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Page 15 of 18[42]. Studies applying the astrocyte inhibitor, fluoroace-
tate, demonstrated the important role of hyperactive tri-
geminal astrocytes in oro-facial neuropathic pain [43].
How these activated glial cells affect pain processing is
always a hot topic and has not been fully answered.
Proinflammatory cytokines have been suggested as sig-
nalling molecules between activated glial cells and their
surrounding neurons to enhance pain transmission. In
the absence of injury, central application of IL-1b and
TNF-a induced allodynia and/or hyperalgesia [44,45].
Intrathecal administration of IL-1ra and soluble TNF-a
[46,47] reduced enhanced nociceptive states. Unexpect-
edly, our results revealed that, in contrast with LPS
induced microglial activation, mental nerve injury-
induced CNS microglial activation had a specific pheno-
type with very low cytokine production profile, which is
consistent with what we have observed previously in
sciatic nerve injury-induced cytokine expression within
the spinal cord [48]. Although such a low level of cyto-
kine expression on highly activated microglia leads us to
question the importance of glia-derived cytokines as a
link in glia-to-neuron interactions and in the pathogen-
esis of neuropathic pain, we still cannot exclude the
involvement of proinflammatory cytokines in this speci-
fic condition. Indeed, since cytokines act in autocrine
and paracrine manner, they might need only to be pro-
duced in very low amounts to be functional. It is also
possible that the level of proinflammatory cytokines is
not enough to maintain hyperactivity of surrounding
neurons, but might contribute to neuropathic pain
though an indirect pathway, e.g., triggering functional
changes of astrocytes and modulating the integrity of
the blood-brain barrier. At the same time, it should be
noticed that in the CNS microenvironment, proinflam-
matory cytokines are not exclusively secreted by acti-
vated glial cells. Indeed, damaged central primary
afferent terminals have been shown to release these
inflammatory molecules [49] and even blood born circu-
lating cytokines can contribute to increase the local con-
centration in the microenvironment (unpublished
personal data). In addition, growing evidence suggests
that many other candidates expressed by activated
microglia can contribute to modulate pain processing,
such as cell surface receptors (P2X4, P2X7, CCR2,
CX3CR1, etc) [50-54], enzymes [55] and complement
components [56]. Evidence of CNS glial involvement in
peripheral inflammatory pain is less substantial. Our
results did not provide neither spatial nor temporal cor-
relation between LPS- and CFA-induced CNS glial reac-
tion and enhanced pain behaviour. However, some
studies using other inflammatory stimuli, such as appli-
cation of inflammatory irritant mustard oil in the tooth
pulp, demonstrated that inhibition of P38 MAPK signal-
ing and inhibition of astrocytes metabolic processes can
completely abolish central sensitization in Sp5C noci-
ceptive neurons [57,58].
In summary, this study identifies the distinctive phe-
notype of CNS glial cells in response to remote nerve
injury and to local infection/inflammation, which all
produced enhanced pain behaviour. It also specifies that
both microglial and astrocytic activations are multi-
dimensional. Functional and morphological changes
were not time-locked, as one could be detected in the
absence of the other, depending on the stimulus that
triggered activation. Further functional studies will help
to delineate whether and how CNS glial cells contribute
to different pathological pain conditions.
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